Navigation Links
Ambulatory Services of America, Inc. Announces Joint Venture to Operate Chicago-Area Radiation Oncology Facility
Date:7/2/2008

NASHVILLE, Tenn., July 2 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the formation of ROSA of Northern Illinois, LLC, its fifth joint venture to provide outpatient radiation oncology services. ROSA of Northern Illinois is a joint venture between Nuclear Oncology Facilities, LLC and ASA's subsidiary, Radiation Oncology Services of America, Inc. ROSA of Northern Illinois will own and operate the DuPage Oncology Center in the Chicago, Illinois area, which was previously owned and operated by Nuclear Oncology Facilities.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO)

ROSA of Northern Illinois will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), in the DuPage Oncology Center. The joint venture expects to build on Nuclear Oncology Facilities' legacy of providing high-quality cancer care to the residents of the Chicago area. Nuclear Oncology, S.C. will provide medical director services for ROSA of Northern Illinois.

Dennis Galinsky, M.D. of Nuclear Oncology, S.C., said, "We are happy to partner with Radiation Oncology Services of America and Ambulatory Services of America to operate the DuPage Cancer Center. As we selected a partner we were looking for a company that would work to support our growth in the Chicago area and help us evaluate and implement new technologies to treat cancer. I believe ROSA and ASA will be just such a partner."

Timothy Martin, President and Chief Executive Officer of ASA, said, "We are happy to enter the Chicago marketplace with such a strong group of physician partners. Nuclear Oncology includes many of Chicago's leading radiation oncologists, and we are honored to be selected as their partners. We look forward to working with them to provide excellent care to cancer patients in and around Chicago."

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Renal Services of America, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services. After the acquisition, ASA will own interests in and operate 41 dialysis centers and 13 radiation oncology centers in nine states and the territory of Guam. ASA also manages three other dialysis centers.


'/>"/>
SOURCE Ambulatory Services of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
2. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
5. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
6. Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP
7. Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg
8. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
9. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
10. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
11. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes ... Risk Test to find out if they are at risk for developing Type 2 ... the evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank ...
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer ... the Siemens Healthineers annual customer education symposium, a world-class learning conference that offers ... March 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. ...
(Date:3/28/2017)... ... March 29, 2017 , ... The ... Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March 1, ... questions regarding thyroid function. , Dr. Izabella Wentz is a licensed pharmacist ...
(Date:3/28/2017)... WA (PRWEB) , ... March 28, 2017 , ... ... a 22% share of all holidays (IBT World Travel Trends Report). As travelers ... challenging, include a range in temperatures, and prolonged sun exposure. In response, the ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... , March 28, 2017  Rosen Law Firm, ... of a class action lawsuit on behalf of purchasers ... KTOV ) pursuant and/or traceable to Kitov,s initial public ... and/or on the open market from November 20, 2015 ... Period"). The lawsuit seeks to recover damages for Kitov ...
(Date:3/28/2017)... Summary GBI ... a Key Component of Multichannel Marketing" provides a ... in the digital age. While the pharmaceutical ... advancements, it has been much slower to adopt ... traditional channels and methods. However, the decreasing effectiveness ...
Breaking Medicine Technology: